Literature DB >> 8380535

Herpes simplex virus from respiratory tract secretions: epidemiology, clinical characteristics, and outcome in immunocompromised and nonimmunocompromised hosts.

D Schuller1, C Spessert, V J Fraser, D M Goodenberger.   

Abstract

PURPOSE: The purpose of this study was to review the course of patients with herpes simplex virus (HSV) recovered from respiratory tract secretions, and to compare the demographics, clinical characteristics, and outcomes of immunocompromised versus nonimmunocompromised patients. PATIENTS AND METHODS: Retrospective review of medical records of 42 consecutive patients who had respiratory tract cultures positive for HSV-1 between May 1988 and August 1990 at a major university-affiliated hospital.
RESULTS: Twenty-seven patients (64%) were not immunocompromised. On the average, the nonimmunocompromised patients were 20 years older (mean age: 67 +/- 15, p = 0.001), had a higher incidence of tobacco smoking (p = 0.04), and were more frequently endotracheally intubated prior to HSV isolation (p = 0.002). Nonimmunocompromised patients more frequently had bronchospasm (44% versus 7%, p = 0.01), leukocytosis (16,400 versus 6,900/mm3, p = 0.001), and difficulty weaning from mechanical ventilation (63% versus 13%, p = 0.002). Mortality was also greater in the nonimmunocompromised group (70% versus 33%, p = 0.02). In addition, for survivors, days of mechanical ventilation (8 +/- 7 versus 2 +/- 4, p = 0.03), length of stay in the intensive care unit (10 +/- 8 versus 2 +/- 4 days, p = 0.004), and length of stay in the hospital (37 +/- 23 versus 16 +/- 14 days, p = 0.04) were all significantly longer for the nonimmunocompromised patients.
CONCLUSION: These data suggest that HSV isolation from lower respiratory secretions is associated with a more severe presentation and a worse outcome in immunocompetent patients than in immunosuppressed patients.

Entities:  

Mesh:

Year:  1993        PMID: 8380535     DOI: 10.1016/0002-9343(93)90116-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Comment on: "Nosocomial viral ventilator-associated pneumonia in the intensive care unit" by Daubin et al.

Authors:  Lavi Oud
Journal:  Intensive Care Med       Date:  2006-02-01       Impact factor: 17.440

2.  Herpetic bronchitis with a broncho-oesophageal fistula.

Authors:  D P Remy; T V Kuzmowych; P K Rohatgi; L G Ortega
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

3.  Viral-Reactivated Pneumonia during Mechanical Ventilation: Is There Need for Antiviral Treatment?

Authors:  Alejandra López-Giraldo; Salvador Sialer; Mariano Esperatti; Antoni Torres
Journal:  Front Pharmacol       Date:  2011-11-08       Impact factor: 5.810

Review 4.  Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome.

Authors:  Steven Nye; Richard J Whitley; Michele Kong
Journal:  Front Pediatr       Date:  2016-11-24       Impact factor: 3.418

Review 5.  Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome.

Authors:  Charles-Édouard Luyt; Alain Combes; Jean-Louis Trouillet; Ania Nieszkowska; Jean Chastre
Journal:  Presse Med       Date:  2011-11-16       Impact factor: 1.228

Review 6.  Lower respiratory tract viral infections: Diagnostic role of exfoliative cytology.

Authors:  Rafael Martínez-Girón; Liron Pantanowitz
Journal:  Diagn Cytopathol       Date:  2017-03-01       Impact factor: 1.582

7.  HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report.

Authors:  Johannes Sumer; Frederike Waldeck; Nadja Fischer; Christina Appenzeller; Markus Koster; Martin Früh; Werner C Albrich
Journal:  Pneumonia (Nathan)       Date:  2021-01-25

8.  Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.

Authors:  Matthias N Witt; Gerald S Braun; Stephan Ihrler; Holger Schmid
Journal:  BMC Pulm Med       Date:  2009-05-18       Impact factor: 3.317

9.  Herpes simplex virus type 1 and normal protein permeability in the lungs of critically ill patients: a case for low pathogenicity?

Authors:  Joanne Verheij; A B Johan Groeneveld; Albertus Beishuizen; Arthur van Lingen; Alberdina M Simoons-Smit; Rob J M Strack van Schijndel
Journal:  Crit Care       Date:  2004-03-31       Impact factor: 9.097

10.  A case of herpes simplex virus pneumonia detected by sputum cytodiagnosis.

Authors:  Mayumi Yoshimi; Yu Satou; Masaya Mori
Journal:  Clin Case Rep       Date:  2017-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.